OLYMPUS CORPORATION (OCPNF) Financials
OCPNF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 10.4 billion | 5.1 billion |
| 2023-09-30 | 10.8 billion | 5.3 billion |
| 2023-06-30 | 11.7 billion | 5.4 billion |
| 2023-03-31 | 11.4 billion | 6.5 billion |
OCPNF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -128.6 million | ? |
| 2023-09-30 | 183.6 million | ? |
| 2023-06-30 | -470.3 million | ? |
| 2023-03-31 | 166.5 million | ? |
OCPNF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 240.4 million |
| 2023-09-30 | -134.7 million |
| 2023-06-30 | 2.5 billion |
| 2023-03-31 | 364.4 million |
OCPNF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 2.7 billion | - | - |
| 2023-09-30 | 3.5 billion | - | - |
| 2023-06-30 | 4.0 billion | - | - |
| 2023-03-31 | 1.4 billion | - | - |
OCPNF Shares Outstanding
OCPNF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 120.9 million | 183.8 million | 845.8 million | - |
| 2023-09-30 | 93.1 million | 131.8 million | 755.6 million | - |
| 2023-06-30 | 102.9 million | 106.2 million | 752.5 million | - |
| 2023-03-31 | 161.4 million | 191.5 million | 861.8 million | - |
OCPNF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.7 billion | 539.4 million |
| 2023-09-30 | 1.5 billion | 520.2 million |
| 2023-06-30 | 1.4 billion | 487.7 million |
| 2023-03-31 | 1.8 billion | 581.6 million |
OCPNF
Price: $16.08
Dividend Yield: 1.17%
Forward Dividend Yield: 0.83%
Payout Ratio: 63.19%
Dividend Per Share: 0.13 USD
Earnings Per Share: 0.14 USD
P/E Ratio: 48.33
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 17.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 10
DGR3: 30.00%
DGR5: 30.00%